A quality by design (QbD) approach solved a high-performance liquid chromatography analytical method problem where impurity peaks had shifting retention times, which made identification and quantitation problematic.
Biopharmaceuticals are increasingly complex and on shorter timelines to meet patient needs. Here's an in-depth look at the latest market drivers, approaches, and technologies in flexible manufacturing.
Gain insight into analytical techniques that reveal answers during product development, with an emphasis on Raman spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry (MS).
With the Better Treatments by Design process, Catalent aims to achieve optimal outcomes for innovators, prescribers, and patients. By applying advanced dose design principles early, we can help you achieve optimal absorption profiles as well as improve patient adherence and compliance, leading to greater payer acceptance, more scripts, and potentially better patient outcomes.